Get the Stockscreener App
14.89
2.91%
0.4397
Overview
News
Price History
Option Chain
Financials
Why FMC Down?
Discussions
Forecast
Stock Split
Dividend History
Fmc Corp stock is traded at $14.89, with a volume of 572.57K.
It is up +2.91% in the last 24 hours and up +0.27% over the past month.
FMC is a pure-play global crop protection company with a fairly balanced product portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop protection companies and focuses on the development of new products, including biologicals, through its research and development pipeline.
See More
Previous Close:
$14.45
Open:
$14.56
24h Volume:
572.57K
Relative Volume:
0.15
Market Cap:
$1.86B
Revenue:
$3.47B
Net Income/Loss:
$-2.20B
P/E Ratio:
-0.832
EPS:
-17.8972
Net Cash Flow:
$-176.50M
1W Performance:
-13.40%
1M Performance:
+0.27%
6M Performance:
-51.17%
1Y Performance:
-63.54%
1-Day Range:
$14.28
$14.91
1-Week Range:
$14.04
$17.44
52-Week Range:
$12.17
$44.78
Fmc Corp Stock (FMC) Company Profile
Name
Fmc Corp
Sector
Industry
Phone
215-299-6668
Address
2929 WALNUT STREET, PHILADELPHIA, PA
Compare FMC vs CTVA, NTR, CF, MOS, ICL
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
FMC
Fmc Corp
|
14.90 | 1.81B | 3.47B | -2.20B | -176.50M | -17.90 |
CTVA
Corteva Inc
|
79.26 | 53.46B | 17.40B | 1.20B | 2.82B | 1.5836 |
NTR
Nutrien Ltd
|
71.16 | 34.74B | 26.89B | 2.30B | 2.01B | 4.6618 |
CF
Cf Industries Holdings Inc
|
121.62 | 19.29B | 7.08B | 1.80B | 1.80B | 8.9928 |
MOS
Mosaic Company
|
23.82 | 7.72B | 12.05B | 575.40M | -534.60M | 1.6871 |
ICL
Icl Group Ltd
|
5.175 | 6.72B | 7.15B | 280.00M | 137.88M | 0.1749 |
Fmc Corp Stock (FMC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-25 | Downgrade | Barclays | Equal Weight → Underweight |
| Nov-11-25 | Resumed | Wells Fargo | Equal Weight |
| Oct-31-25 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Oct-31-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Oct-30-25 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-14-25 | Upgrade | BofA Securities | Underperform → Neutral |
| Jun-23-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Apr-25-25 | Upgrade | Mizuho | Neutral → Outperform |
| Mar-13-25 | Initiated | Goldman | Buy |
| Feb-14-25 | Downgrade | Redburn Atlantic | Buy → Neutral |
| Feb-07-25 | Downgrade | UBS | Buy → Neutral |
| Feb-05-25 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Jan-21-25 | Upgrade | Barclays | Equal Weight → Overweight |
| Jan-14-25 | Upgrade | BofA Securities | Underperform → Neutral |
| Oct-23-24 | Initiated | Citigroup | Neutral |
| Jun-26-24 | Initiated | Barclays | Equal Weight |
| Mar-01-24 | Initiated | Wolfe Research | Peer Perform |
| Feb-12-24 | Downgrade | Loop Capital | Buy → Hold |
| Feb-07-24 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
| Jan-16-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Jan-04-24 | Initiated | ROTH MKM | Buy |
| Dec-14-23 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Dec-07-23 | Downgrade | Mizuho | Buy → Neutral |
| Oct-24-23 | Downgrade | BofA Securities | Buy → Neutral |
| Oct-24-23 | Downgrade | Goldman | Buy → Neutral |
| Oct-24-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-16-23 | Upgrade | Vertical Research | Hold → Buy |
| Sep-25-23 | Downgrade | Redburn Atlantic | Overweight → Neutral |
| Sep-05-23 | Downgrade | UBS | Buy → Neutral |
| Aug-21-23 | Initiated | JP Morgan | Neutral |
| Aug-04-23 | Upgrade | Credit Suisse | Underperform → Neutral |
| Jul-24-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Mar-17-23 | Upgrade | Redburn | Neutral → Buy |
| Jan-19-23 | Resumed | Wells Fargo | Overweight |
| Jan-10-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Nov-15-22 | Upgrade | Loop Capital | Hold → Buy |
| Jul-20-22 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jun-21-22 | Upgrade | BofA Securities | Underperform → Buy |
| Jun-13-22 | Downgrade | Redburn | Buy → Neutral |
| May-31-22 | Initiated | Credit Suisse | Underperform |
| Apr-14-22 | Downgrade | Loop Capital | Buy → Hold |
| Mar-31-22 | Downgrade | Monness Crespi & Hardt | Buy → Neutral |
| Mar-22-22 | Downgrade | BofA Securities | Buy → Underperform |
| Feb-10-22 | Reiterated | Citigroup | Buy |
| Feb-10-22 | Reiterated | Mizuho | Buy |
| Feb-10-22 | Reiterated | Monness Crespi & Hardt | Buy |
| Feb-10-22 | Reiterated | Wells Fargo | Overweight |
| Jan-31-22 | Initiated | Redburn | Buy |
| Jan-11-22 | Upgrade | Citigroup | Neutral → Buy |
| Nov-29-21 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-18-21 | Upgrade | Loop Capital | Hold → Buy |
| Oct-13-21 | Initiated | Mizuho | Buy |
| Oct-11-21 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jun-24-21 | Downgrade | Vertical Research | Buy → Hold |
| May-06-21 | Downgrade | Citigroup | Buy → Neutral |
| Feb-11-21 | Upgrade | Monness Crespi & Hardt | Neutral → Buy |
| Sep-17-20 | Initiated | UBS | Buy |
| Mar-26-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Mar-13-20 | Upgrade | BofA/Merrill | Neutral → Buy |
| Oct-16-19 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Oct-16-19 | Initiated | Wells Fargo | Outperform |
| Sep-18-19 | Initiated | Exane BNP Paribas | Outperform |
| Aug-09-19 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Aug-02-19 | Upgrade | Goldman | Neutral → Buy |
| Aug-01-19 | Downgrade | BofA/Merrill | Buy → Neutral |
| Jun-13-19 | Resumed | Citigroup | Buy |
| May-20-19 | Initiated | Morgan Stanley | Equal-Weight |
| Apr-18-19 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Mar-21-19 | Reiterated | Jefferies | Buy |
| Mar-08-19 | Resumed | Goldman | Neutral |
| Nov-14-18 | Initiated | Buckingham Research | Buy |
| Nov-09-18 | Resumed | Loop Capital | Buy |
| Nov-05-18 | Resumed | Citigroup | Buy |
| Nov-05-18 | Resumed | Credit Suisse | Outperform |
| May-14-18 | Upgrade | Goldman | Neutral → Buy |
| May-04-18 | Upgrade | Stephens | Equal-Weight → Overweight |
View All
Fmc Corp Stock (FMC) Latest News
RBC Capital Maintains FMC Corp(FMC.US) With Hold Rating, Cuts Target Price to $16 - 富途牛牛
Earnings Preview: FMC Corp to Report Financial Results Post-market on April 29 - Moomoo
FMC Corp. stock underperforms Thursday when compared to competitors - MarketWatch
FMC Corp. Stock Hits Day Low of $14.53 Amid Price Pressure - Markets Mojo
Is FMC Corp. stock seriously undervalued? - MSN
A Look at FMC Corp (FMC) After 7.4% Decline -- GF Value $44.90 v - GuruFocus
FMC Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
FMC Faces Downgrade as Financial Challenges Loom - GuruFocus
FMC (NYSE:FMC) Cut to Sell at Vertical Research - MarketBeat
Vertical Research Downgrades FMC Corp(FMC.US) to Sell Rating, Cuts Target Price to $14 - 富途牛牛
FMC (FMC) to Release Earnings on Wednesday - MarketBeat
FMC Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
$FMC Stock Is Down 9% Today. Here's What We See in Our Data. - Moomoo
$FMC stock is down 9% today. Here's what we see in our data. - Quiver Quantitative
FMC Stock Declines by 5.5% - GuruFocus
FMC SEC FilingsFmc Corp 10-K, 10-Q, 8-K Forms - Stock Titan
FMC Maintained by Wells Fargo -- Price Target Raised to $17.00 - GuruFocus
BofA Securities Maintains FMC Corp(FMC.US) With Hold Rating, Raises Target Price to $19 - Moomoo
FMC Corp stock (US3448491049): Is agricultural resilience now the key to steady returns? - AD HOC NEWS
FMC Corp. stock outperforms competitors on strong trading day - MarketWatch
FMC Corp stock (US3024913036): Why Google Discover changes matter more now - AD HOC NEWS
FMC Corp. stock (US3024913036): Why agricultural chemical resilience matters more now for investors? - AD HOC NEWS
Expedia Group Inc stock (US3024913036): Is travel demand recovery strong enough to drive sustained m - AD HOC NEWS
FMC Corp. stock underperforms Friday when compared to competitors - MarketWatch
FMC (FMC) director receives 71 dividend-equivalent shares, now holds 31,705 - Stock Titan
FMC (FMC) director gains 40 shares via dividend equivalent rights - Stock Titan
[Form 4] FMC CORP Insider Trading Activity - Stock Titan
Dividend equivalents add 135 FMC (NYSE: FMC) shares to director - Stock Titan
FMC (FMC) director gains 107 shares via dividend equivalent rights - Stock Titan
Director at FMC (NYSE: FMC) receives 202 new common shares - Stock Titan
Director at FMC (NYSE: FMC) granted 84 shares via dividends - Stock Titan
FMC (FMC) director receives 248-share dividend-equivalent stock grant as holdings reach 60,670 - Stock Titan
FMC (NYSE: FMC) director adds 17 shares through dividend equivalent grant - Stock Titan
FMC Corp (FMC) director granted 12 shares via dividend rights - Stock Titan
Dividend-equivalent share grant boosts FMC (NYSE: FMC) director holdings - Stock Titan
FMC (FMC) CEO Brondeau receives 29-share stock grant through dividend rights - Stock Titan
Old North State Wealth Management Exits Entire FMC Corp Stake - HarianBasis.co
Why This $4.4 Million Exit Looks Bearish for a Chemicals Stock Down 50% - The Motley Fool
Barclays Maintains FMC Corp(FMC.US) With Sell Rating, Maintains Target Price $13 - Moomoo
Mizuho Securities Maintains FMC Corp(FMC.US) With Buy Rating, Raises Target Price to $21 - 富途牛牛
Goldman Sachs Maintains FMC Corp(FMC.US) With Buy Rating, Maintains Target Price $21 - 富途牛牛
FMC Corp (FMC) climbs 6.66% ahead of dividends, earnings - MSN
FMC Maintained by Goldman Sachs -- Price Target Raised to $21.00 - GuruFocus
FMC Corp. stock (US3024913036): Is its agchem competitive edge strong enough to unlock new upside? - AD HOC NEWS
FMC (NYSE:FMC) Price Target Raised to $21.00 at The Goldman Sachs Group - MarketBeat
Goldman Sachs Maintains FMC Corp(FMC.US) With Buy Rating, Raises Target Price to $21 - 富途牛牛
FMC Corp. stock (US3024913036): Why agricultural chemical resilience now matters more for investors? - AD HOC NEWS
FMC Corp (FMC) Shares Surge 3.5% -- What GF Score of 55 Tells In - GuruFocus
FMC: New CFO Appointed to Strengthen Financial Leadership - GuruFocus
Citi Keeps a Neutral Rating on FMC Corporation (FMC) - Insider Monkey
FMC: UBS Raises Price Target While Maintaining Neutral Rating | - GuruFocus
Fmc Corp Stock (FMC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
1.52%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):